CIGNA INVESTMENTS INC /NEW

Q2 2022 13F Holdings Report, Stock Holdings

Signature - Title
Lisa Candera - Chief Compliance Officer
Location
Bloomfield, CT
Holdings as of
June 30, 2022
Value $
$499M
Num holdings
454
Date filed
8/15/2022, 11:17 AM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q1 2022 - May 13, 2022
Next filing
Q3 2022 - Nov 14, 2022
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2022 Q2 compared to 2022 Q1 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Lisa Candera Chief Compliance Officer Bloomfield, Connecticut 8/15/2022

Other Included Managers (9):

Num Name Location File Number
1 Connecticut General Life Insurance Company
2 CIGNA VENTURES, LLC
3 Cigna Health and Life Insurance Company
4 Cigna Holding Co 028-01157
5 NewQuest, LLC
6 Cigna Foundation
7 Cigna HealthCare of North Carolina, Inc.
8 LINA Life Insurance Company of Korea
9 Evernorth Behavioral Health of Texas, Inc.